European Heart Journal Advance Access originally published online on November 30, 2004
European Heart Journal 2005 26(1):5-7; doi:10.1093/eurheartj/ehi055
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorial
Obesity and heart failure prognosis: paradox or reverse epidemiology?
Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
* Corresponding author. Tel: +1 504 842 5874; fax: +1 504 842 5875. E-mail address: clavie@ochsner.org
| The first 10% of the full text of this article appears below. |
Obesity is a problem reaching epidemic proportions in westernized society and is a major cause of preventable death.1 Obesity has many adverse effects on coronary artery disease (CAD) risk factors and is probably an independent risk factor for CAD events. Epidemiological studies have clearly shown a strong relationship between obesity and increased risk of cardiovascular disease and mortality in the general population,1,2 although in some of these studies a J-shaped or U-shaped curve has been present, meaning that those individuals with low body mass index (BMI) also have increased mortality.
Obesity is also known to exert numerous adverse effects on cardiac function. In early obesity, an expanded intravascular volume results in an increase in cardiopulmonary volume or increased pre-load.1,3 Over time these
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function
- Finn Gustafsson, Charlotte B. Kragelund, Christian Torp-Pedersen, Marie Seibæk, Hans Burchardt, Dilek Akkan, Jens Jakob Thune, Lars Køber, and for the DIAMOND study group
EHJ 2005 26: 58-64.[Abstract] [Full Text]
This article has been cited by other articles:
![]() |
S. Kenchaiah, S. J. Pocock, D. Wang, P. V. Finn, L. A.M. Zornoff, H. Skali, M. A. Pfeffer, S. Yusuf, K. Swedberg, E. L. Michelson, et al. Body Mass Index and Prognosis in Patients With Chronic Heart Failure: Insights From the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program Circulation, August 7, 2007; 116(6): 627 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsutamoto, T. Tanaka, H. Sakai, C. Ishikawa, M. Fujii, T. Yamamoto, and M. Horie Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure Eur. Heart J., July 2, 2007; 28(14): 1723 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lavie, R. V. Milani, H. O. Ventura, and M. R. Mehra Peak Oxygen Consumption and Heart Failure Prognosis in Women J. Am. Coll. Cardiol., January 23, 2007; 49(3): 375 - 375. [Full Text] [PDF] |
||||
![]() |
X. Kang, L. J. Shaw, S. W. Hayes, R. Hachamovitch, A. Abidov, I. Cohen, J. D. Friedman, L. E.J. Thomson, D. Polk, G. Germano, et al. Impact of Body Mass Index on Cardiac Mortality in Patients With Known or Suspected Coronary Artery Disease Undergoing Myocardial Perfusion Single-Photon Emission Computed Tomography J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1418 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ryan Risks and benefits of weight loss: challenges to obesity research Eur. Heart J. Suppl., November 1, 2005; 7(suppl_L): L27 - L31. [Abstract] [Full Text] [PDF] |
||||



